Dong-bo Chen

Beijing Key Laboratory Of Hepatitis C And Immunotherapy For Liver Diseases
Beijing, 100044, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

AADN score: Predicting response to transarterial chemoembolization, sintilimab and lenvatinib in patients with hepatocellular carcinoma.

AADN score: Predicting response to transarterial chemoembolization, sintilimab and lenvatinib in patients with hepatocellular carcinoma.

Journal: World journal of gastroenterology

Published: September 09, 2025

Immune checkpoint molecules signal regulatory protein alpha in the development of hepatocellular carcinoma.

Immune checkpoint molecules signal regulatory protein alpha in the development of hepatocellular carcinoma.

Journal: World journal of gastrointestinal oncology

Published: May 26, 2025

Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection.

Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection.

Journal: World journal of gastroenterology

Published: February 11, 2023

The BcLAE1 is involved in the regulation of ABA biosynthesis in Botrytis cinerea TB-31.

The BcLAE1 is involved in the regulation of ABA biosynthesis in Botrytis cinerea TB-31.

Journal: Frontiers in microbiology

Published: June 15, 2022

Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China.

Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China.

Journal: World journal of gastroenterology

Published: February 14, 2022

Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma.

Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma.

Journal: World journal of gastrointestinal oncology

Published: February 20, 2021

RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A.

RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A.

Journal: Scientific reports

Published: April 26, 2020

Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.

Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.

Journal: Chinese medical journal

Published: June 13, 2019

Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.

Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.

Journal: American journal of cancer research

Published: April 08, 2019

Analyzing hematopoietic development of mouse embryonic AGM region by tissue culture

Analyzing hematopoietic development of mouse embryonic AGM region by tissue culture

Journal: Zhongguo shi yan xue ye xue za zhi

Published: November 02, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026